v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net Income $ 110.6 $ 125.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 55.3 45.6
Impairment charges 0.0 28.3
Loss on sale of assets 0.1 0.2
Gain on divestitures 0.0 (4.0)
Deferred income tax (benefit) provision (4.3) 2.8
Stock-based compensation expense 4.5 11.0
Pension and other postretirement expense 1.6 0.4
Pension and other postretirement benefit contributions and payments (12.2) (4.8)
Changes in operating assets and liabilities:    
Accounts receivable (106.1) (50.3)
Unbilled receivables 9.5 (11.1)
Inventories (11.1) 6.1
Accounts payable, trade 20.7 (9.4)
Other accrued expenses (31.2) (44.8)
Income taxes 24.8 (15.0)
Other, net (12.9) (2.1)
Net Cash Provided by Operating Activities 49.3 78.6
Investing Activities    
Capital expenditures (44.1) (41.7)
Acquisitions, net of cash acquired (0.2) (29.2)
Proceeds from divestitures, net of cash divested 0.0 5.7
Investments in short-term marketable securities, net 19.7 0.8
Other, net 0.1 (0.1)
Net Cash Used in Investing Activities (24.5) (64.5)
Financing Activities    
Cash dividends paid to shareholders (24.5) (23.6)
Purchase of treasury shares 0.0 (54.0)
Proceeds from exercise of stock options 2.0 12.7
Payments related to tax withholding for stock-based compensation (8.9) (13.8)
Borrowings on accounts receivable facility 30.0 29.0
Payments on accounts receivable facility (22.0) (14.0)
Proceeds from long-term debt 203.3 137.0
Payments on long-term debt (196.9) (82.7)
Short-term debt activity, net 2.0 (8.1)
Net Cash Used in Financing Activities (15.0) (17.5)
Effect of exchange rate changes on cash (6.8) 1.8
Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 3.0 (1.6)
Cash, cash equivalents and restricted cash at beginning of year 419.3 340.7
Cash, Cash Equivalents and Restricted Cash at End of Period $ 422.3 $ 339.1